Kbc Group Nv Cytokinetics Inc Transaction History

Kbc Group Nv

$36.3 Billion
Q4 2024

A detailed history of Kbc Group Nv transactions in Cytokinetics Inc stock. As of the latest transaction made, Kbc Group Nv holds 5,134 shares of CYTK stock, worth $256,545. This represents 0.0% of its overall portfolio holdings.

Number of Shares

5,134

Previous 3,232 58.85%

Holding current value

$256,545

Previous $171,000 41.52%

% of portfolio

0.0%

Previous 0.0%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Jan 22, 2025	BUY	$46.36 - $58.62 $88,176 - $111,495	1,902 Added 58.85%	5,134 $242,000
Q3 2024 Nov 06, 2024	BUY	$51.22 - $60.16 $43,588 - $51,196	851 Added 35.74%	3,232 $171,000
Q2 2024 Jul 17, 2024	BUY	$47.86 - $75.05 $17,325 - $27,168	362 Added 17.93%	2,381 $129,000
Q1 2024 May 08, 2024	SELL	$63.75 - $108.06 $20,846 - $35,335	-327 Reduced 13.94%	2,019 $142,000
Q4 2023 Feb 13, 2024	SELL	$26.88 - $83.49 $136,550 - $424,129	-5,080 Reduced 68.41%	2,346 $196,000
Q3 2023 Feb 15, 2024	SELL	$29.46 - $36.61 $149,656 - $185,978	-5,080 Reduced 68.41%	2,346 $69,000
Q2 2023 Feb 15, 2024	SELL	$32.62 - $40.75 $13,928 - $17,400	-427 Reduced 5.44%	7,426 $242,000
Q2 2023 Jul 28, 2023	SELL	$32.62 - $40.75 $13,928 - $17,400	-427 Reduced 5.44%	7,426 $242,000
Q4 2022 Feb 14, 2024	BUY	$35.77 - $51.11 $49,147 - $70,225	1,374 Added 21.21%	7,853 $360,000
Q3 2022 Feb 15, 2024	BUY	$38.54 - $54.52 $212,239 - $300,241	5,507 Added 234.74%	7,853 $380,000
Q3 2022 Nov 08, 2022	BUY	$38.54 - $54.52 $52,953 - $74,910	1,374 Added 21.21%	7,853 $380,000
Q2 2022 Feb 14, 2024	BUY	$33.93 - $48.92 $128,730 - $185,602	3,794 Added 141.3%	6,479 $255,000
Q2 2022 Jul 26, 2022	BUY	$33.93 - $48.92 $128,730 - $185,602	3,794 Added 141.3%	6,479 $255,000
Q1 2022 Feb 14, 2024	BUY	$29.74 - $46.0 $10,081 - $15,594	339 Added 14.45%	2,685 $99,000
Q1 2022 May 06, 2022	BUY	$29.74 - $46.0 $79,851 - $123,510	2,685 New	2,685 $99,000

Others Institutions Holding CYTK

# of Institutions

406

Shares Held

125M

Call Options Held

4.61M

Put Options Held

2.46M

View Full List

About CYTOKINETICS INC

Ticker CYTK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 94,144,096
Market Cap $4.7B
Description
Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...

More about CYTK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Kbc Group Nv, based on Form 13F filings with the SEC.

News

Stay updated on Kbc Group Nv with notifications on news.

Account